Aurobindo Pharma said that it received final approval from US FDA for Lamotrigine tablets (chewable, dispersible) of 5 mg and 25 mg strengths.
Lamotrigine tablets of 5 mg and 25 mg is generic equivalent to Lamictal CD tablets of 5 mg and 25 mg tablets of GlaxoSmithKline.
Lamotrigine tablets fall under the CNS segment and is indicated as adjunctive therapy for partial seizures and generalized seizures of Lennox-Gastaut syndrome in patients aged 2 years and older and for monotherapy in adults with partial seizures who are receiving treatment with a single enzyme-including anti-epileptic drug. The product is to be launched soon.
For comments and feedback contact: editorial@rttnews.com
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.